
S3E9| David Regan + Nanotech and the Future of Cancer Treatment
No se pudo agregar al carrito
Add to Cart failed.
Error al Agregar a Lista de Deseos.
Error al eliminar de la lista de deseos.
Error al añadir a tu biblioteca
Error al seguir el podcast
Error al dejar de seguir el podcast
-
Narrado por:
-
De:
Hosts James Collins and Alec Cranston return for a fresh episode packed with local stories, science, and innovation. The two sit with David Regan, CEO of Sona Nanotech. David shares the fascinating story behind Sona’s breakthrough gold nanorod technology, which enables targeted hyperthermia cancer therapy. We learn how these nanoparticles are tuned to specific wavelengths, injected into tumors, and then activated by near-infrared light to selectively destroy cancer cells while sparing healthy tissue. David explains the science, the company’s journey from rapid COVID-19 test development to cancer therapy, and the importance of Atlantic Canada’s innovation ecosystem.
Follow Matter Of 'Fax: https://www.instagram.com/matteroffaxpodcast/
Follow James: https://www.instagram.com/teamcollinsns/
Follow Alec: https://www.instagram.com/aleccranston9/
Follow the Reddit Roundup threads: https://www.reddit.com/r/halifax/comments/18jd9nw/nothing_says_grand_reopening_like_discount_broth/
https://www.reddit.com/r/halifax/s/btAf0ArhMh